The current study's findings that letrozole-induced PCOS mice have dyslipidemia, oxidative stress, impaired glucometabolic regulation, and decreased adiponectin concentration in serum and ovarian tissue are consistent with a previous study that revealed metabolic dysregulation in adiponectin-deficient mice [45]. Here, ADIPOQ is linked to metabolic syndrome.